HIV/AIDS Diagnostics Market - Global Industry Analysis

Global HIV/AIDS Diagnostics Market: Overview

HIV/AIDS diagnostics are used to examine the presence of the human immune-deficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), in saliva, serum or urine. HIV/AIDS diagnostics helps to detect antibodies, RNA or antigens. Blood tests are the most regular way to make a diagnosis of HIV. HIV is most commonly diagnosed by doing a urine test and blood test.

Report Scope:

Global HIV/AIDS Diagnostics Market: Growth Factors

According to WHO research, until now around 75 million people are infected with human immune-deficiency virus (HIV) and around 30 million people died of HIV disease. With the growing mortality rate, the government and non-government organizations are taking major initiatives to increase the awareness among the people regarding HIV/AIDS and are also providing economic help for diagnostic management thus driving the HIV/AIDS diagnostics market. With the progression of technology, novel diagnostic products are easily accessible in the market which needs the least amount of technical skills that fasten the diagnosis process. In developing countries such as China and India where a growing population is becoming a major concern, increasing awareness about HIV, and up-coming economies will be the major driving factor for HIV/AIDS diagnostics market. Rise in incidence of HIV infection, knowledge about HIV/AIDs diagnosis and treatment, growing research & development for treatment, early diagnosis, and prevention are the other major factors boosting the HIV/AIDS diagnostics market.

Global HIV/AIDS Diagnostics Market: Segmentation

The HIV/AIDS diagnostics market is divided based on the product type, test type, and end-user. Based on the product type, the HIV/AIDS diagnostics market has been classified into instruments, kits and reagents, and others. Based on the test type, the HIV/AIDS diagnostics market is categorized into nucleic acid tests, rapid tests (POC), ELISA, and others. Based on the end users, the global HIV/AIDS diagnostics market is divided into private diagnostics laboratories, hospitals, research institutes & others, and academic.

Global HIV/AIDS Diagnostics Market: Regional Analysis

Regionally, the global HIV/AIDS diagnostics market is classified into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa. North America anticipates dominating the HIV/AIDS diagnostics market with the highest market share. In the future years, the region is anticipated to hold on to its leading position by growing at a tremendous rate in the years to come. This development is due to the growing awareness about the various HIV/AIDS diagnosis, test, several initiatives taken by the government to prevent HIV, and expansion in research and development facilities. It is expected that North America will be followed by Europe and the Asia Pacific. It is also anticipated that in the coming years the Middle East will witness sluggish growth rate due to lack of awareness.

Global HIV/AIDS Diagnostics Market: Competitive Players

Some of the major companies in the global HIV/AIDS diagnostics market are Hologic, Inc., Alere, Bio-Rad Laboratories, Abbott Laboratories, F. Hoffmann-La Roche Ltd., OraSure Technologies, Inc., Siemens Healthineers, and Chembio Diagnostic Systems among others.

Global HIV/AIDS Diagnostics Market: Regional Segment Analysis

• North America
  • The U.S.
• Europe
  • The UK
  • France
  • Germany
• The Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.